Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30

By Alex Sirois Published May 15, 12:19PM EDT

Quick Read

Policy tailwinds from refrigerant regulations, EV production incentives, and aerospace demand are creating execution catalysts for American manufacturers trading below $30 that have structural support beyond near-term valuations.
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Chemours wasn't one of them. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30 — © Bill Pugliano / Getty Images

American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition, EV plant buildouts, and aerospace demand are pushing capital back into U.S. factories, yet the share prices of several domestic producers still sit in deep-value territory. With manufacturing contributing $2,961.4 billion to GDP in Q4 2025 and policy tailwinds aligning, stocks under $30 in this corner of the market look less like cheap names and more like asymmetric setups.

With that in mind, here are three American manufacturing stocks trading under $30 where the bull case is starting to take shape.

Chemours (NYSE: CC)

Chemours (NYSE:CC | CC Price Prediction) is a Wilmington, Delaware specialty chemicals maker known for titanium dioxide, refrigerants, and advanced performance materials like Teflon and Nafion.

At $25.26, Chemours sits well inside the under-$30 window, but the chart tells a recovery story: shares are up 115.28% year to date and 134.38% over the past year. Q1 2026 delivered adjusted EPS of $0.05 versus a -$0.05 consensus, a 225% beat on $1.381 billion in revenue. The analyst target sits at $25.78 with a forward P/E of 14.

The bull case is the refrigerant transition. Thermal & Specialized Solutions net sales rose 22% to $568 million with Freon pricing up 67% in North America and Opteon up 12%, all driven by the AIM Act phasedown of legacy refrigerants. Management used $287 million in Kuan Yin sale proceeds to pay down €140 million in Euro term loans and reiterated FY2026 Adjusted EBITDA guidance of $800 to $900 million.

The risk: net leverage of 4.9x and unresolved PFAS litigation remain real overhangs. Even so, with a domestic refrigerant manufacturing footprint, regulatory tailwinds, and active deleveraging, Chemours fits the renaissance template.

Rivian (NASDAQ: RIVN)

Rivian (NASDAQ:RIVN) builds the R1T truck, R1S SUV, the upcoming mass-market R2, and electric delivery vans for Amazon at its Normal, Illinois plant.

Shares trade at $14.08, down 28.56% year to date. Q1 2026 showed deliveries up 20% YoY to 10,365 vehicles, revenue of $1.381 billion (+11.37% YoY), and adjusted EPS of -$0.54 versus a -$0.7162 estimate.

The bull case is the catalyst stack. The R2 is in production with a bill of materials roughly 50% of the R1 and external deliveries beginning imminently. Volkswagen completed a $1 billion equity investment, the Uber robotaxi deal could bring up to $1.25 billion through 2031, and a $4.5 billion DOE loan backstops the Georgia facility targeting 300,000 units of annual capacity. Software & Services revenue jumped 49% YoY to $473 million at 34% gross margins.

The risk is cash burn: free cash flow of -$1.075 billion and FY2026 adjusted EBITDA guidance of -$2.10 to -$1.80 billion. If R2 ramps cleanly, Rivian becomes the clearest pure-play on American EV manufacturing scale.

Huntsman (NYSE: HUN)

Huntsman (NYSE:HUN) is a Woodlands, Texas specialty chemicals producer focused on polyurethanes (MDI), performance products, and advanced materials for aerospace.

At $14.84, Huntsman is up 49.48% year to date and pays a 4.58% dividend yield with a price-to-book ratio of 0.978. Q1 2026 EPS of -$0.20 beat the -$0.2053 consensus on $1.42 billion in revenue (+0.7% YoY).

The bull case rides on aerospace and a cyclical turn. Advanced Materials revenue grew 12% YoY to $279 million with adjusted EBITDA up 25% to $45 million, driven by aerospace demand. Polyurethanes volumes grew 4% YoY and management implemented worldwide pricing increases. CEO Peter Huntsman expects “a step up in profitability” in Q2 2026.

The risk: a credit downgrade, elevated net debt, and Middle East feedstock volatility could push recovery into 2027. For investors comfortable with cyclicality, Huntsman offers exposure to U.S. aerospace and reshored chemicals at a discount to book value.

The Bottom Line

A share price below $30 is only a starting point for research. Each of these names carries real execution risk, and small-cap manufacturers can swing sharply on macro and commodity inputs. Treat this list as a research starting point and confirm any name fits your timeline and risk tolerance before acting.

Follow 24/7 Wall St. on Google

About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.